Literature DB >> 18196244

Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility.

Berna Tander1, Sezgin Gunes, Omer Boke, Gamze Alayli, Nurten Kara, Hasan Bagci, Ferhan Canturk.   

Abstract

Genetic and environmental factors are thought to play roles in the etiopathology of fibromyalgia syndrome (FMS). The objective of this study was to determine the potential effects of single nucleotide polymorphisms (SNPs) in catechol-O-methyltransferase (COMT) (rs4680) and 5-hydroxytryptamine (serotonin) 2A (5-HT2A) receptor (rs6313 and rs6311) genes on susceptibility to FMS. One hundred seventy-one women (80 FMS, 91 control) were enrolled in the study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for the genotyping analyses. Genotype and allele frequencies were calculated by the chi-square test. Beck depression inventory, state and trait anxiety inventory and symptom checklist-90 revised (SCL-90-R) tests were applied to both patients and controls. There were no observed differences in the frequencies of alleles and genotypes between patients and controls for the COMT, and the two 5-HT2A receptor gene polymorphisms (P>0.05). Our results suggest that the investigated polymorphisms seem not to be the susceptibility factors in etiology of FMS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18196244     DOI: 10.1007/s00296-008-0525-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

1.  Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A.

Authors:  M A Enoch; D Goldman; R Barnett; L Sher; C M Mazzanti; N E Rosenthal
Journal:  Mol Psychiatry       Date:  1999-01       Impact factor: 15.992

2.  Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits.

Authors:  Hagit Cohen; Dan Buskila; Lily Neumann; Richard P Ebstein
Journal:  Arthritis Rheum       Date:  2002-03

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Association of T102C polymorphism of the 5-HT2A receptor gene with psychiatric status in fibromyalgia syndrome.

Authors:  S Gürsoy; E Erdal; H Herken; E Madenci; B Alaşehirli
Journal:  Rheumatol Int       Date:  2001-10       Impact factor: 2.631

5.  COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yolanda R Smith; Joshua A Bueller; Ke Xu; Yanjun Xu; Robert A Koeppe; Christian S Stohler; David Goldman
Journal:  Science       Date:  2003-02-21       Impact factor: 47.728

6.  Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.

Authors:  Savaş Gürsoy; Emin Erdal; Hasan Herken; Ercan Madenci; Belgin Alaşehirli; Nurten Erdal
Journal:  Rheumatol Int       Date:  2002-10-22       Impact factor: 2.631

7.  Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients.

Authors:  Bernd Frank; Beate Niesler; Brigitta Bondy; Michael Späth; Dieter E Pongratz; Manfred Ackenheil; Christine Fischer; Gudrun Rappold
Journal:  Clin Rheumatol       Date:  2004-05-07       Impact factor: 2.980

8.  The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4.

Authors:  Shan-Yu Su; Jonathan Jiunn-Horng Chen; Chien-Chen Lai; Chun-Ming Chen; Fuu-Jen Tsai
Journal:  Clin Rheumatol       Date:  2006-03-18       Impact factor: 2.980

9.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

10.  Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.

Authors:  Ali Sazci; Emel Ergul; Ismail Kucukali; Gamze Kilic; Guner Kaya; Ihsan Kara
Journal:  Brain Res Mol Brain Res       Date:  2004-12-06
View more
  24 in total

1.  Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.

Authors:  Young Ho Lee; Jae-Hoon Kim; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2014-06-21       Impact factor: 2.631

2.  Genome-wide expression profiling in the peripheral blood of patients with fibromyalgia.

Authors:  Kim D Jones; Terri Gelbart; Thomas C Whisenant; Jill Waalen; Tony S Mondala; David N Iklé; Daniel R Salomon; Robert M Bennett; Sunil M Kurian
Journal:  Clin Exp Rheumatol       Date:  2016-02-12       Impact factor: 4.473

Review 3.  Candidate gene studies of fibromyalgia: a systematic review and meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 4.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

5.  Assessment of opioid receptor μ1 gene A118G polymorphism and its association with pain intensity in patients with fibromyalgia.

Authors:  Özlem Solak; Müjgan Özdemir Erdoğan; Handan Yıldız; Alper Murat Ulaşlı; Fatima Yaman; Evrim Suna Arıkan Terzi; Sena Ulu; Ümit Dündar; Mustafa Solak
Journal:  Rheumatol Int       Date:  2014-03-27       Impact factor: 2.631

6.  COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia.

Authors:  Patrick H Finan; Alex J Zautra; Mary C Davis; Kathryn Lemery-Chalfant; Jonathan Covault; Howard Tennen
Journal:  Pain       Date:  2010-12-03       Impact factor: 6.961

7.  Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia.

Authors:  Shad B Smith; Dylan W Maixner; Roger B Fillingim; Gary Slade; Richard H Gracely; Kirsten Ambrose; Dmitri V Zaykin; Craig Hyde; Sally John; Keith Tan; William Maixner; Luda Diatchenko
Journal:  Arthritis Rheum       Date:  2012-02

Review 8.  Pathophysiology of fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

9.  Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study.

Authors:  Kate L Holliday; Gary J Macfarlane; Barbara I Nicholl; Francis Creed; Wendy Thomson; John McBeth
Journal:  J Psychosom Res       Date:  2010-05       Impact factor: 3.006

10.  Complex multilocus effects of catechol-O-methyltransferase haplotypes predict pain and pain interference 6 weeks after motor vehicle collision.

Authors:  Andrey V Bortsov; Luda Diatchenko; Samuel A McLean
Journal:  Neuromolecular Med       Date:  2013-08-21       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.